• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.更正：抗PD-1治疗患者肺肿瘤组织中CD8和PD-L1检测的预后及预测作用
Br J Cancer. 2019 Jul;121(3):283. doi: 10.1038/s41416-019-0512-8.
2
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.抗 PD-1 治疗患者肺肿瘤组织中 CD8 和 PD-L1 测定的预后和预测作用。
Br J Cancer. 2018 Oct;119(8):950-960. doi: 10.1038/s41416-018-0220-9. Epub 2018 Oct 15.
3
Correction: Development and validation of a novel risk score for the detection of insignificant prostate cancer in unscreened patient cohorts.更正：一种用于在未筛查患者队列中检测非显著性前列腺癌的新型风险评分的开发与验证
Br J Cancer. 2019 Apr;120(7):771. doi: 10.1038/s41416-019-0408-7.
4
Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.程序性细胞死亡配体1（PD-L1）、CD8 +肿瘤浸润淋巴细胞和p53在非小细胞肺癌中的预后意义：一项免疫组织化学研究
Turk Patoloji Derg. 2017;1(1):211-222. doi: 10.5146/tjpath.2017.01398.
5
Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.在接受同步放化疗的 III 期非小细胞肺癌患者中，PD-L1 表达与 CD8 + 肿瘤浸润淋巴细胞密度联合的预测相关性
Eur J Cancer. 2016 Mar;55:7-14. doi: 10.1016/j.ejca.2015.11.020. Epub 2016 Jan 6.
6
Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.PD-L1表达和CD8 + T细胞浸润在肺神经内分泌肿瘤中的预后意义
Diagn Pathol. 2018 May 22;13(1):30. doi: 10.1186/s13000-018-0712-1.
7
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
8
Prognostic value of tumor PD-L1 expression combined with CD8 tumor infiltrating lymphocytes in high grade serous ovarian cancer.肿瘤 PD-L1 表达联合 CD8 肿瘤浸润淋巴细胞对高级别浆液性卵巢癌的预后价值。
Int Immunopharmacol. 2017 Nov;52:7-14. doi: 10.1016/j.intimp.2017.08.017. Epub 2017 Aug 31.
9
Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.PD-L1 表达和 CD8+T 细胞浸润在 EGFR 突变和 ALK 重排肺癌患者中的临床意义。
Lung Cancer. 2018 Nov;125:86-92. doi: 10.1016/j.lungcan.2018.09.010. Epub 2018 Sep 14.
10
Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases.程序性细胞死亡配体（PD-L1）在 II 期和 III 期肺腺癌及淋巴结转移中的表达。
J Thorac Oncol. 2017 Mar;12(3):458-466. doi: 10.1016/j.jtho.2016.10.015. Epub 2016 Nov 2.

引用本文的文献

1
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy.非小细胞肺癌与肿瘤微环境：从靶向治疗迈向先进免疫治疗的进展
Front Immunol. 2025 Feb 10;16:1515748. doi: 10.3389/fimmu.2025.1515748. eCollection 2025.
2
Analysis of PD-1/PD-L1 variations in lung cancer and association with immunotherapeutic efficacy and prognosis: A nonrandomized controlled trial.分析肺癌中 PD-1/PD-L1 的变异与免疫治疗疗效和预后的关系：一项非随机对照试验。
Clinics (Sao Paulo). 2024 Jun 8;79:100395. doi: 10.1016/j.clinsp.2024.100395. eCollection 2024.
3
APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma.APOBEC突变特征可预测非吸烟肺腺癌患者的预后和免疫治疗反应。
Transl Lung Cancer Res. 2023 Mar 31;12(3):580-593. doi: 10.21037/tlcr-23-150.
4
Prediction of Survival Rate and Chemotherapy Effect by an Immune Score Model in Colorectal Cancer.免疫评分模型预测结直肠癌的生存率和化疗效果。
Biomed Res Int. 2022 Apr 4;2022:8219701. doi: 10.1155/2022/8219701. eCollection 2022.
5
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade.肿瘤微环境在肺癌中的治疗意义：聚焦免疫检查点阻断。
Front Immunol. 2022 Jan 7;12:799455. doi: 10.3389/fimmu.2021.799455. eCollection 2021.

更正：抗PD-1治疗患者肺肿瘤组织中CD8和PD-L1检测的预后及预测作用

Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.

作者信息

Fumet Jean-David, Richard Corentin, Ledys Fanny, Klopfenstein Quentin, Joubert Philippe, Routy Bertrand, Truntzer Caroline, Gagné Andréanne, Hamel Marc-André, Guimaraes Camila Figueiredo, Coudert Bruno, Arnould Laurent, Favier Laure, Lagrange Aurélie, Ladoire Sylvain, Saintigny Pierre, Ortiz-Cuaran Sandra, Perol Maurice, Foucher Pascal, Hofman Paul, Ilie Marius, Chevrier Sandy, Boidot Romain, Derangere Valentin, Ghiringhelli François

机构信息

Department of Medical Oncology, Center GF Leclerc, Dijon, France.

Research Platform in Biological Oncology, Dijon, France.

出版信息

Br J Cancer. 2019 Jul;121(3):283. doi: 10.1038/s41416-019-0512-8.

DOI:10.1038/s41416-019-0512-8
PMID:31235866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6738095/
Abstract

Since the publication of this paper, the authors noticed that Corentin Richard was not credited as contributing equally to the paper. He should be considered as a joint first author with Jean-David Fumet.

摘要

自本文发表以来，作者们注意到科伦丁·理查德未被认定为对本文有同等贡献。他应被视为与让 - 大卫·富梅共同的第一作者。